Command Palette

Search for a command to run...

VILINBIO
25.5(+0.00%)
1W: -4.49%

Vilin Bio Med Peer Comparison

Snapshot Summary

Vilin Bio Med Ltd. shows no current financial metrics, indicating it is still in the early stages of development. However, its peers demonstrate a diverse range of performance metrics, with Sun Pharmaceutical Industries and Dr. Reddy's Laboratories leading in profitability and efficiency. Companies like Cipla and Mankind Pharma are also noteworthy for their solid growth and reasonable valuations, positioning them as strong contenders in the pharmaceutical sector.

  • Vilin Bio Med Ltd. has no available financial data, suggesting it is not yet operational or lacks market presence.
  • Sun Pharmaceutical leads in profitability with a ROE of 16.13% and a PE ratio of 87.59.
  • Cipla and Dr. Reddy's are noted for their strong growth metrics and efficient operations, making them attractive investments.
  • Mankind Pharma shows significant revenue growth, indicating strong market demand.
  • Divi's Laboratories and Torrent Pharmaceuticals are struggling with high PE ratios relative to their growth.
  • Sun Pharmaceutical Industries Ltd.: Highest ROE and solid profitability metrics.
  • Dr. Reddy's Laboratories Ltd.: Strong growth in EPS and ROE, making it a strong competitor.
  • Cipla Ltd.: Good revenue growth and strong efficiency metrics.
  • Mankind Pharma Ltd.: Exceptional revenue growth trajectory.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
VILINBIO--0.00--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.